Fougera - a division of ALTANA Inc Make No Compromises  
  About FougeraPhysicians & PharmacistsConsumer InformationKnowledge Center  
  Fougera - leading the world in manufacturing, marketing and distributing generic skin topicals  
Contact Us         FAQs           Helpful Links           Search the Site           Careers           Home
News: Press Releases
5.6.2008
FOUGERA FIRST-TO-MARKET WITH CALCIPOTRIENE TOPICAL SOLUTION 0.005% (Rx) (SCALP SOLUTION)

2.21.2008
NYCOMED US INC. ACQUIRES BRADLEY PHARMACEUTICALS, INC.

1.16.2007
Nycomed Officially Launched as Combined Group

11.17.2006
FOUGERA RECEIVES APPROVAL FOR FIRST GENERIC SULFACETAMIDE SODIUM TOPICAL SUSPENSION USP 10% (Rx)

6.6.2006
FOUGERA FIRST-TO-MARKET WITH METRONIDAZOLE TOPICAL GEL USP 0.75% (Rx)

5.24.2006
FOUGERA FIRST-TO-MARKET WITH METRONIDAZOLE LOTION 0.75% (RX)

9.30.2005
ALTANA INC ACQUIRES US DERMATOLOGY BUSINESS

9.16.2005
FOUGERA® RECEIVES FIRST TENTATIVE GENERIC APPROVAL FOR METROGEL®

9.13.2005
Fougera® Accelerates Availability of Emergency Care Products to Gulf States

8.9.2005
Fougera Marks Fifth Snakebite Season with CroFab® -

8.1.2005
FOUGERA UPGRADES WEB SITE FOR PHARMACISTS AND HEALTH PROFESSIONALS

7.13.2005
Fougera Extends Line with Introduction of Clotrimazole & Betamethasone Dipropionate Lotion Usp 1%/0.05% (base) (Rx)

5.12.2005
ALTANA Inc Inaugurates 100,000 Sq. Ft. Of Manufacturing Space In Hicksville, New York - Leading Pharmaceutical Manufacturer Cites Growth And Increased Demand For Topical Drugs Behind Expansion

4.11.2005
Fougera Announces Approval Of Mometasone Furoate Cream And Ointment (Rx)

1.19.2005
Fougera® Announces Diversification Of Crofab® Production

1.18.2005
Fougera® Aids In South Asia Disaster Relief; Topical Generic Manufacturer Provides Product And Cash Assistance To Tsunami Victims

1.18.2005
Fougera Introduces Two New Ophthalmics: Gentamicin Sulfate Ophthalmic Ointment USP (Sterile)(Rx) And Gentamicin Sulfate Ophthalmic Solution USP 0.3% (Sterile)(Rx)

1.3.2005
ALTANA Helps Flood Victims In South Asia

12.29.2004
Fougera Announces The First Approval Of Ciclopirox Olamine Cream USP (Rx)

12.16.2004
Fougera Announces The Approval Of Halobetasol Cream 0.05% (Rx) and Ointment 0.05% (Rx)

9.7.2004
Paul B. McGarty Named As Chief Executive Officer Of Fougera


Browse the Fougera Product Listing
      A      B      C      D      E      F      G      H      I      J      K      L      M      N      O      P      Q      R      S      T      U      V      W      X      Y      Z      

*All topical Generic (RX) products have been approved by FDA as being therapeutically equivalent to the reference listed drug.
Some reference products are no longer available.
All products made in the USA

Fougera, Melville, NY 11747
Toll Free: 800.645.9833
© 2008 Fougera.com. All rights reserved.
Disclaimer